Resveratrol in Treating Diabetes and Its Cardiovascular Complications: A Review of Its Mechanisms of Action
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Diabetes mellitus (DM) is one of the most prevalent chronic diseases worldwide. High morbidity and mortality caused by DM are closely linked to its complications in multiple organs/tissues, including cardiovascular complications, diabetic nephropathy, and diabetic neuropathy. Resveratrol is a plant-derived polyphenolic compound with pleiotropic protective effects, ranging from antioxidant and anti-inflammatory to hypoglycemic effects. Recent studies strongly suggest that the consumption of resveratrol offers protection against diabetes and its cardiovascular complications. The protective effects of resveratrol involve the regulation of multiple signaling pathways, including inhibition of oxidative stress and inflammation, enhancement of insulin sensitivity, induction of autophagy, regulation of lipid metabolism, promotion of GLUT4 expression, and translocation, and activation of SIRT1/AMPK signaling axis. The cardiovascular protective effects of resveratrol have been recently reviewed in the literature, but the role of resveratrol in preventing diabetes mellitus and its cardiovascular complications has not been systematically reviewed. Therefore, in this review, we summarize the pharmacological effects and mechanisms of action of resveratrol based on in vitro and in vivo studies, highlighting the therapeutic potential of resveratrol in the prevention and treatment of diabetes and its cardiovascular complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 1×
“This promotes the formation and fusion of autophagosomes and lysosomes into autophagic lysosomes [90,91].”
BackgroundResveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057 · cited 3×
“Resveratrol also protects mitochondrial function and improves insulin resistance in obese mice by increasing PGC-1α activity [21].”
BackgroundSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796 · cited 1×
“Resveratrol can activate and upregulate NAD+ dependent SIRT1 [37], thereby improving or delaying the development of diabetes, cardiovascular disease, cancer, and other diseases [38–40].”
BackgroundModulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579 · cited 1×
“The accumulation of a burst of ROS in cells that cannot be cleared leads to oxidative stress response in the body, resulting in tissue and cell damage [61].”
BackgroundAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · cited 1×
“AMPK activates FOXOs through phosphorylation or co-action with SIRT1, triggering the expression of antioxidant enzymes to restore cardiac function [55].”
BackgroundStress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130 · cited 1×
“Resveratrol also activates PGC-1α through the AMPK-SIRT1 signaling pathway, further activating PPAR and thus playing a role in lipid metabolism [96].”
BackgroundRubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107
Price, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V., Martin-Montalvo, A., North, B. J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.003 · Cited by 1,602 · cited 1×
“Specifically, in a dose of resveratrol less than 25 μM, AMPK was completely dependent on SIRT1, while when the dose of resveratrol was increased to 50 μM, AMPK seemed to function independently of SIRT1 [54].”
BackgroundTriggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201 · cited 1×
“The molecular mechanisms of resveratrol may be through lowering ATP levels or modulating metabolic disorders to protect pancreatic function in patients with diabetes [86,88].”
BackgroundMizushima, N., & Levine, B. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2022774 · Cited by 1,140 · cited 1×
“The consequence of autophagy is to degrade the contents of their wrapping, and through this process realize the metabolic needs of the cells and the renewal of certain organelles [89].”
BackgroundCalorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS
Nisoli, E., Tonello, C., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Falcone, S., Valerio, A., Cantoni, O., Clementi, E., et al. (2005) · Science · doi:10.1126/science.1117728 · Cited by 1,107
SIRT1 Improves Insulin Sensitivity under Insulin-Resistant Conditions by Repressing PTP1B
Sun, C., Zhang, F., Ge, X., Yan, T., Chen, X., Shi, X., & Zhai, Q. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.014 · Cited by 766
Russell, R. R., Li, J., Coven, D. L., Pypaert, M., Zechner, C., Palmeri, M., Giordano, F. J., Mu, J., Birnbaum, M. J., & Young, L. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19297 · Cited by 738
Sirt1 Regulates Insulin Secretion by Repressing UCP2 in Pancreatic β Cells
Bordone, L., Motta, M. C., Picard, F., Robinson, A., Jhala, U. S., Apfeld, J., McDonagh, T., Lemieux, M., McBurney, M., Szilvasi, A., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0040031 · Cited by 715 · cited 2×
“Activation of SIRT1 inhibits the expression of intracellular uncoupling protein-1 (UCP-1), further leading to increased insulin secretion and improved insulin resistance [84].”
BackgroundFOXO1 couples metabolic activity and growth state in the vascular endothelium
Wilhelm, K., Happel, K., Eelen, G., Schoors, S., Oellerich, M. F., Lim, R., Zimmermann, B., Aspalter, I. M., Franco, C. A., Boettger, T., et al. (2016) · Nature · doi:10.1038/nature16498 · Cited by 579
Dong, X. C., Copps, K. D., Guo, S., Li, Y., Kollipara, R., DePinho, R. A., & White, M. F. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.006 · Cited by 463 · cited 1×
“The occurrence of diabetes can lead to a decrease in SIRT1 activity and its expression, and then the enhanced acetylation of FOXO1 will lead to a significant increase in blood glucose in vivo after FOXO1 activation, which may ultimately aggravate insulin resistance [44].”
BackgroundAMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
Ruderman, N., & Prentki, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1344 · Cited by 451
Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review
Meng, X., Zhou, J., Zhao, C.-N., Gan, R.-Y., & Li, H.-B. (2020) · Foods · doi:10.3390/foods9030340 · Cited by 387
Kitada, M., Kume, S., Imaizumi, N., & Koya, D. (2011) · Diabetes · doi:10.2337/db10-0386 · Cited by 345
Diabetes-induced hyperglycemia impairs male reproductive function: A systematic review
Maresch, C. C., Stute, D. C., Alves, M. G., Oliveira, P. F., de Kretser, D. M., & Linn, T. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmx033 · Cited by 294 · cited 1×
“DM is currently classified as type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational diabetes mellitus, and special type DM [1,2].”
BackgroundOxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes
Odegaard, A. O., Jacobs, D. R., Sanchez, O. A., Goff, D. C., Reiner, A. P., & Gross, M. D. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0369-6 · Cited by 286 · cited 1×
“At present, it is known that oxidative stress is one of the major contributors to diabetes and its complications as well as the pathogenesis of cardiovascular diseases [62,63].”
BackgroundZheng, Z., Chen, H., Li, J., Li, T., Zheng, B., Zheng, Y., Jin, H., He, Y., Gu, Q., & Xu, X. (2012) · Diabetes · doi:10.2337/db11-0416 · Cited by 282
AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633
Chen, Z., Peng, I.-C., Sun, W., Su, M.-I., Hsu, P.-H., Fu, Y., Zhu, Y., DeFea, K., Pan, S., Tsai, M.-D., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.187567 · Cited by 264
Li, A., Zhang, S., Li, J., Liu, K., Huang, F., & Liu, B. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.06.008 · Cited by 197
Zhu, X., Wu, C., Qiu, S., Yuan, X., & Li, L. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0217-z · Cited by 196
Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol
Xia, N., Strand, S., Schlufter, F., Siuda, D., Reifenberg, G., Kleinert, H., Förstermann, U., & Li, H. (2013) · Nitric Oxide · doi:10.1016/j.niox.2013.04.001 · Cited by 157
Xi, J., Wang, H., Mueller, R. A., Norfleet, E. A., & Xu, Z. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.12.024 · Cited by 123
Metabolic effects of resveratrol: Addressing the controversies
Bitterman, J. L., & Chung, J. H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1808-8 · Cited by 109 · cited 1×
“This pathway is accomplished through the increase in cAMP, which promotes signaling cascades [58].”
BackgroundChong, E., Chang, S.-L., Hsiao, Y.-W., Singhal, R., Liu, S.-H., Leha, T., Lin, W.-Y., Hsu, C.-P., Chen, Y.-C., Chen, Y.-J., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.01.044 · Cited by 93
Tauriainen, E., Luostarinen, M., Martonen, E., Finckenberg, P., Kovalainen, M., Huotari, A., Herzig, K.-H., Lecklin, A., & Mervaala, E. (2011) · Journal of Nutrition and Metabolism · doi:10.1155/2011/525094 · Cited by 81
Chen, L.-L., Zhang, H.-H., Zheng, J., Hu, X., Kong, W., Hu, D., Wang, S.-X., & Zhang, P. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.002 · Cited by 81 · cited 2×
“Furthermore, resveratrol can also increase mitochondrial oxidation and reduce lipid accumulation in skeletal muscles [79].”
BackgroundGómez-Zorita, S., Fernández-Quintela, A., Lasa, A., Hijona, E., Bujanda, L., & Portillo, M. P. (2013) · Nutrition · doi:10.1016/j.nut.2013.04.014 · Cited by 79
Evidence supporting a mechanistic role of sirtuins in mood and metabolic disorders
Alageel, A., Tomasi, J., Tersigni, C., Brietzke, E., Zuckerman, H., Subramaniapillai, M., Lee, Y., Iacobucci, M., Rosenblat, J. D., Mansur, R. B., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.05.017 · Cited by 45
Brawerman, G. M., Kereliuk, S. M., Brar, N., Cole, L. K., Seshadri, N., Pereira, T. J., Xiang, B., Hunt, K. L., Fonseca, M. A., Hatch, G. M., et al. (2019) · The Journal of Physiology · doi:10.1113/jp278082 · Cited by 40 · cited 1×
“6 mg/kg, oral for 12 weeks ↓Dysregulated gluconeogenesis ↓Dysregulation of several metabolic genes [31]”
Background
Cited by
Das, D., Shruthi, N. R., Banerjee, A., Jothimani, G., Duttaroy, A. K., & Pathak, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1221438 · Cited by 90
Dhiman, S., Mannan, A., Taneja, A., Mohan, M., & Singh, T. G. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122537 · Cited by 25
Melkis, K., & Jakubczyk, K. (2024) · Foods · doi:10.3390/foods13101488 · Cited by 17
“…vinegar may positively affect the functioning of the body, as they exhibit antioxidant, anti-inflammatory, anti-diabetic, anti-cancer, cardio-protective, prebiotic effects, as well as beneficial effects on cognitive function, contributing to the reduction of neurodegenerative diseases [70–74].”
Background
Metadata
- Authors
- Su, M., Zhao, W., Xu, S., & Weng, J.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2022-05-30
- Volume
- 11
- Issue
- 6
- Pages
- 1085
- ISSN
- 2076-3921 (ISSN-L)
- OpenAlex
- W4282028812
- Cited by
- 113
- References
- 36
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.